A detailed history of Sage Mountain Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sage Mountain Advisors LLC holds 1,159 shares of VRTX stock, worth $573,252. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,159
Previous 1,162 0.26%
Holding current value
$573,252
Previous $544,000 0.92%
% of portfolio
0.05%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$460.0 - $505.78 $1,380 - $1,517
-3 Reduced 0.26%
1,159 $539,000
Q2 2024

Jul 31, 2024

BUY
$392.81 - $485.53 $165,373 - $204,408
421 Added 56.82%
1,162 $544,000
Q1 2024

Apr 23, 2024

BUY
$407.69 - $446.08 $25,684 - $28,103
63 Added 9.29%
741 $309,000
Q4 2023

Feb 01, 2024

BUY
$343.0 - $410.68 $4,802 - $5,749
14 Added 2.11%
678 $275,000
Q3 2023

Oct 25, 2023

BUY
$338.18 - $362.46 $15,218 - $16,310
45 Added 7.27%
664 $230,000
Q2 2023

Jul 24, 2023

BUY
$314.42 - $351.91 $194,625 - $217,832
619 New
619 $217,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $127B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sage Mountain Advisors LLC Portfolio

Follow Sage Mountain Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Mountain Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Mountain Advisors LLC with notifications on news.